Fundraising FoxTriWise Capital
Venture capitalShenzhen · Pre-Seed–Series B · 1 people tracked
Find your way into TriWise Capital
Sign up to see every warm intro you have to TriWise Capital
- Paths you didn't know you had: your email and LinkedIn already hold routes to the TriWise Capital team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Investment thesis
TriWise Capital pursues a philosophy of 'investment returning to industry, capital serving industry,' emphasizing original and value investing across the healthcare ecosystem. It focuses on frontier technologies such as innovative drugs, cell and gene therapy, synthetic biology, biological breeding, and high-end medical devices. Leveraging partnerships with national medical device innovation centers, the Chinese Academy of Sciences Shenzhen Institute of Advanced Technology, and biomedical translation institutes, the firm targets early-stage companies with high growth potential and strong industry barriers. Its model combines roughly 30% investment with 70% services, effectively co-founding ventures with entrepreneurial teams and providing post-investment support to help commercialize scientific research results.
Source: firm website, verified Aug 3, 2026.
Team · 1 people
from the firm's websiteWhat they invest in
from 2 of 2 portfolio companiesBiotech ×2Medical Devices ×2FemTech ×1
HQs:China×1United States×1
Investments · 2 tracked
founders shown can be your intro path
Asieris (亚虹医药) is a pharmaceutical company developing diagnostic and therapeutic products focused on women's reproductive health and urologic cancers, including treatments for cervical precancerous lesions and bladder cancer.
BiotechFemTechMedical Devices
Kevin Pan(Founder)
Co-investorsEFung CapitalQiming Venture PartnersYF Capital
Immune Onc is a biotechnology company developing medicines to treat patients with hard-to-treat cancers and autoimmune diseases, with expertise in translational medicine and clinical development.
BiotechMedical DevicesPalo Alto, US
Xiaoling Charlene Liao(Executive Officer, Director)Charlene Liao(Founder)in
BoardGuo-Liang Yu(Director)Liqun Luo(Director)
Co-investorsCLI VenturesNorthern Light Venture CapitalShangBay Capital LLCStartXVivo Capital
Frequently asked questions
- What stage does TriWise Capital invest at?
- TriWise Capital invests at the Pre-Seed, Seed, Series A, Series B stages.
- What sectors does TriWise Capital focus on?
- TriWise Capital focuses on AgTech, AI & Machine Learning, Biotech, Climate Tech, Deep Tech, Digital Health, Hardware, Healthtech, Medical Devices, Semiconductors.
- Where is TriWise Capital located?
- TriWise Capital is headquartered in Shenzhen, CN.
- Does TriWise Capital lead rounds?
- Yes, TriWise Capital leads investment rounds.
Similar investors
DCVC (Data Collective) is a deep tech venture capital firm that backs entrepreneurs using computational approaches to solve large-scale real-world problems across many industries.
Qbic is an inter-university venture capital fund that backs the transformation of technological breakthroughs from its academic and research partners into sustainable businesses.
SOSV is a deep tech venture capital firm that makes first-check pre-seed investments and follow-on rounds in startups focused on human and planetary health, providing lab space and hands-on support at its US locations.
The Global Startup Acceleration Program (GSAP) is a JETRO initiative, run with Japan's Cabinet Office and top overseas accelerators, that helps Japan-based startups pursue international business development through tailored, equity-free accelerator courses.
OUP (Osage University Partners) is a venture firm that invests in science-driven startups commercializing deep technology innovations emerging from university and breakthrough research.